ArticleThe American journal of pathology2009

Amplification of the urokinase-type plasminogen activator receptor (uPAR) gene in ductal pancreatic carcinomas identifies a clinically high-risk group.

Ralf Hildenbrand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.